Regulation of human papillomavirus type 16 (HPV-16) transcription by loci on the short arm of chromosome 11 is mediated by the TATAAAA motif of the HPV-16 promoter

References

1. Atkin NB, Baker MC. 1984; Non-random chromosome changes in carcinoma of the cervix uteri I. Nine near-diploid tumours. Cancer Genetics and Cytogenetics 7:209–222
   [Google Scholar]
2. Atkin NB, Baker MC. 1988; Deficiency of all or part of chromosome 11 in several types of cancer: significance of a reduction in the number of normal chromosomes 11. Cytogenetics and Cellular Genetics 47:106–107
   [Google Scholar]
3. Berkhout B, Jeang KT. 1992; Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immmunodeficiency virus type 1 long terminal repeat. Journal of Virology 66:139–149
   [Google Scholar]
4. Cereghini S, Raymondjean M, Garcia Carranca A, Herbomel P, Yaniv M. 1987; Factors involved in control of tissue-specific expression of albumin gene. Cell 50:627–638
   [Google Scholar]
5. Crook T, Morgenstern JP, Crawford L, Banks L. 1989; Continued expression of the HPV 16 E7 protein is required for maintenance of the transformed phenotype of cells cotransformed by HPV 16 plus EJ-ras. EMBO Journal 8:513–519
   [Google Scholar]
6. de Villiers EM. 1989; Heterogeneity of the human papillomavirus group. Journal of Virology 63:4898–4903
   [Google Scholar]
7. Dynlacht BD, Hoey T, Tjian R. 1991; Isolation of cofactors associated with the TATA-binding protein that mediate transcriptional activation. Cell 66:563–576
   [Google Scholar]
8. Gorman CM, Moffat LF, Howard BH. 1982; Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Molecular and Cellular Biology 2:1044–1051
   [Google Scholar]
9. Hurlin PJ, Kaur P, Smith PP, Perez-Reyes N, Blanton A, McDougall JK. 1991; Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proceedings of the National Academy of Sciences, U.S.A. 88:570–574
   [Google Scholar]
10. Kaebling M, Klinger HP. 1986; Suppression of tumorigenicity in somatic cell hybrids III. Co-segregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid-malignant cells. Cytogenetics and Cellular Genetics 41:65–70
    [Google Scholar]
11. Koi M, Morita H, Yamada H, Satoh H, Barrett JC, Oshimura M. 1989; Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Molecular Carcinogenesis 2:12–21
    [Google Scholar]
12. Nakajima N, Horikoshi M, Roeder RG. 1988; Factors involved in specific transcription by mammalian RNA polymerase II: purification, genetic specificity, and TATA box-promoter interactions of TFIID. Molecular and Cellular Biology 8:4028–1040
    [Google Scholar]
13. Riccardi VM, Hittner HM, Francke U, Yunis JJ, Ledbetter D, Borges W. 1980; The aniridia-Wilms tumor association: the critical role of chromosome band 11p13. Cancer Genetics and Cytogenetics 2:131–137
    [Google Scholar]
14. Rösl F, Durst M, zur Hausen H. 1988; Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine. EMBO Journal 7:1321–1328
    [Google Scholar]
15. Rösl F, Achtstatter T, Bauknecht T, Futterman G, Hutter KJ, zur Hausen H. 1991; Extinction of the HPV 18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions. EMBO Journal 10:3461–3466
    [Google Scholar]
16. Saxon PJ, Srivatsan ES, Stanbridge EJ. 1986; Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO Journal 5:3461–3466
    [Google Scholar]
17. Seedorf K, Krammer G, Durst M, Rowekamp W. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185
    [Google Scholar]
18. Smits HL, Raadsheer E, Rood I, Mehendale S, Slater RM, van der Noordaa J, ter Schegget J. 1988; Induction of anchorage-independent growth of human embryonic fibroblasts with a deletion in the short arm of chromosome 11 by human papillomavirus type 16 DNA. Journal of Virology 62:4538–4543
    [Google Scholar]
19. Smits PHM, Smits HL, Jebbink MF, ter Schegget J. 1990; The short arm of chromosome 11 likely is involved in the regulation of the human papillomavirus type 16 early enhancer–promoter and in the suppression of the transforming activity of the viral DNA. Virology 176:158–165
    [Google Scholar]
20. von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L. 1988; Correlation of modified human papillomavirus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Research 48:3780–3786
    [Google Scholar]
21. Vousden KH. 1989; Human papillomaviruses and cervical carcinoma. Cancer Cells 1:43–49
    [Google Scholar]
22. Wasylyk B, Derbyshire R, Guy D, Molko D, Roget A, Teoule R, Chambon P. 1980; Specific in vitro transcription of conalbumin gene is drastically decreased by single-point mutations in TATA box homology sequence. Proceedings of the National Academy of Sciences, U.S.A. 77:7024–7028
    [Google Scholar]
23. Wefald FC, Blythe HD, Williams RS. 1990; Functional heterogeneity of mammalian TATA-box sequences revealed by interaction with a cell-specific enhancer. Nature, London 344:260–262
    [Google Scholar]
24. zur Hausen H. 1989; Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Research 79:4677–4681
    [Google Scholar]
25. zur Hausen H. 1991; Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9–13
    [Google Scholar]